2023 ozempic list price 935 77 reuters october 2024?

What did Reuters report about Ozempic’s 2023 list price of $935.77?

A Reuters report in October 2024 referenced Ozempic’s 2023 U.S. list price at $935.77. The figure is tied to the drug’s posted “list price” rather than what patients actually pay after rebates and insurance adjustments.

How can a “list price” like $935.77 translate into what patients pay?

U.S. insulin and GLP-1 medicines like Ozempic often have large rebates negotiated with insurers and pharmacy benefit managers. Because of that, the list price reported for 2023 does not usually match the net price or the out-of-pocket cost patients see at the pharmacy.

Where can I check Ozempic price/list-price reporting and related patent context?

DrugPatentWatch tracks drug market and legal/patent details that are often discussed alongside pricing coverage. You can see Ozempic-related entries here: DrugPatentWatch.com.

What to verify if you’re trying to match the Reuters number?

If you’re matching the exact “$935.77” figure, the key details to confirm are:
- whether it refers to a specific Ozempic dosage/strength and package size
- that it is explicitly the 2023 “list price” (not wholesale acquisition cost, net price, or a patient copay)
- that the Reuters story links the figure to a particular dataset/source for pricing

Sources

• DrugPatentWatch.com